Reporting to the Senior Director, CMC Regulatory Affairs, the Associate Director/Director, CMC Regulatory Affairs is responsible for leading regulatory support for assigned programs in small molecules, biologics and peptides to ensure sound regulatory planning and tactical implementation of US and international development and marketing authorization strategies.
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
Eiger BioPharmaceuticals is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status. Reasonable accommodation will be provided for qualified individuals with disabilities and for qualified disabled veterans in job application procedures, as required by applicable law.
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Eiger has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. If you are unable to receive a COVID-19 vaccine due to a disability, serious medical condition, or because it would violate your sincerely held religious belief, you will have an opportunity to request a reasonable accommodation.
Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other serious rare diseases. The Eiger HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. All five Eiger rare disease programs have been granted FDA Breakthrough Therapy Designation.
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to:
Reporting to the General Counsel, the Associate Director—Legal Operations, Contract Administration and Compliance will work closely with services and technology providers and outside legal counsel to develop and maintain the Company’s corporate legal systems, policies and processes, and will be responsible for supporting the entire contracting process, including preparation, review, tracking, execution and storage of company contracts. This role will also support the corporate compliance function, ensuring the company meets its obligations with regard to payments to HCPs, adheres to its internal controls and appropriately trains employees, contractors and vendors. This individual will provide critical client support activities to internal stakeholders throughout the company. The successful candidate will be nimble and highly self-motivated, with excellent organizational and communication skills, the ability to handle multiple projects and work with a diverse group of legal and functional personnel outside the organization and at all levels within Eiger.
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
Eiger BioPharmaceuticals is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status. Reasonable accommodation will be provided for qualified individuals with disabilities and for qualified disabled veterans in job application procedures, as required by applicable law.
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Eiger has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. If you are unable to receive a COVID-19 vaccine due to a disability, serious medical condition, or because it would violate your sincerely held religious belief, you will have an opportunity to request a reasonable accommodation.
Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other serious diseases. The Eiger HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. All five Eiger rare disease programs have been granted FDA Breakthrough Therapy Designation.
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to:
The Clinical Research Associate (CRA) works as part of the Study Management Team to contribute towards the successful management and execution of clinical trials.
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
Eiger BioPharmaceuticals is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status. Reasonable accommodation will be provided for qualified individuals with disabilities and for qualified disabled veterans in job application procedures, as required by applicable law.
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Eiger has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. If you are unable to receive a COVID-19 vaccine due to a disability, serious medical condition, or because it would violate your sincerely held religious belief, you will have an opportunity to request a reasonable accommodation.
Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases. The Eiger HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. Eiger is also developing peginterferon lambda as a therapeutic for COVID-19 and is planning to submit an emergency use authorization application to FDA based on positive results from the investigator sponsored Phase 3 TOGETHER study. All five Eiger rare disease programs have been granted FDA Breakthrough Therapy designation: lonafarnib and peginterferon lambda for HDV, Zokinvy for progeria, and avexitide for both congenital hyperinsulinism and post-bariatric hypoglycemia.
The Eiger management team has extensive experience in the clinical development and commercialization of a broad range of therapeutics, with special expertise in Orphan Designation drugs. Eiger is located in Palo Alto, California.
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to:
Reports to: SVP, Corporate Affairs
Key Relationships:
Location: Palo Alto
Date Updated: July 2022
FLSA Classification: Exempt
The Director, Human Resources is responsible for implementing and managing talent-related strategies and practices to enhance the continued growth and development of the organization, its people and culture. Serve as a key thought partner to the SVP Corporate Affairs, CEO, and Executive Team; partner closely with leaders to enhance and evolve a relevant and sustainable culture. Specific responsibilities shall include formulating and implementing policies and procedures in the areas of recruiting, compensation, benefits, career development, and training. The Director, Human Resources will support the management of new programs in the areas of onboarding, performance management, and Eiger culture. They will support awareness by employees of the company’s values, behaviors, and other cultural norms. The Director, Human Resources will ensure legal compliance with all local, state and federal HR laws and regulations.
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
Eiger BioPharmaceuticals is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status. Reasonable accommodation will be provided for qualified individuals with disabilities and for qualified disabled veterans in job application procedures, as required by applicable law.
Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Eiger has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. If you are unable to receive a COVID-19 vaccine due to a disability, serious medical condition, or because it would violate your sincerely held religious belief, you will have an opportunity to request a reasonable accommodation.
Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases. The Eiger HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. Eiger is also developing peginterferon lambda as a therapeutic for COVID-19 and reported positive results from TOGETHER, a Phase 3 investigator-initiated study.
All five Eiger rare disease programs have been granted FDA Breakthrough Therapy designation: lonafarnib and peginterferon lambda for HDV, Zokinvy for progeria, and avexitide for both HI and PBH.
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to:
As one of the first colleagues to join the Eiger Medical Affairs field team, you will serve as a founding member of an expanding group that will be critical to the company’s future success. Our MSL field team will be responsible for helping to create and shape the foundation of Eiger’s Medical Affairs initiatives which will include the introduction of our company and our late-stage development programs, with a primary focus on HDV, building a key opinion leader network, developing and maintaining professional relationships with allied healthcare personnel and all external customers, and providing comprehensive medical and scientific support aligned to Eiger development and post approval initiatives. You will work collaboratively with the entire Eiger organization across all functional areas to ensure accurate and appropriate dissemination of information related to our pipeline and therapeutic areas critical to achievement of corporate objectives.
Title(s): Flexible, to be developed based on experience and fit within broader organization plan.
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
EOE
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases.
Eiger’s lead clinical programs are focused on the development of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of viral hepatitis, with two complementary HDV treatments. Lonafarnib is a first-in-class, oral prenylation inhibitor in a global Phase 3 trial. Peginterferon lambda is a first-in-class, type III, well-tolerated interferon entering Phase 3.
Zokinvy® for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) and processing-deficient Progeroid Laminopathies is the Company's first FDA approved product. A Marketing Authorization Application (MAA) is under review by the European Medicines Agency (EMA).
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to:
The Trial Master File (TMF) Specialist is responsible for the day-to-day management of the TMF, including support tasks related to the set-up, maintenance, close out of the TMF and oversight of the review and approval of TMF documents. This role has a strong focus on ensuring that document management operations are performed with adherence to standard operating procedures (SOPs) and ICH GCP/regulatory guidelines and ensuring the TMFs are always inspection ready.
TRAVEL REQUIRED
We offer flexible working models, competitive benefits, and an environment where you will have the opportunity for personal and professional growth.
EOE
The above description is intended to describe the general nature of the job and may include other duties as assumed or assigned; it is not intended to be all inclusive or limit the duties of the position.
Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other serious rare diseases. The Eiger HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. All five Eiger rare disease programs have been granted FDA Breakthrough Therapy Designation.
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Please submit your resume to: